Low Dose Apomorphine and Parkinsonism
Phase 2
Withdrawn
- Conditions
- First Posted Date
- 2007-05-11
- Last Posted Date
- 2018-11-29
- Lead Sponsor
- Oregon Health and Science University
- Registration Number
- NCT00472355
- Locations
- ๐บ๐ธ
Department of Neurology, Oregon Health and Science University, Mail Code OP32, 3181 SW Sam Jackson Park Road, Portland, Oregon, United States
A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD
Phase 3
Completed
- Conditions
- First Posted Date
- 2007-05-04
- Last Posted Date
- 2011-07-22
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 150
- Registration Number
- NCT00469352
- Locations
- ๐บ๐ธ
Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States
Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation
- First Posted Date
- 2006-12-25
- Last Posted Date
- 2013-08-16
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 20
- Registration Number
- NCT00415506
- Locations
- ๐บ๐ธ
Oregon Health & Science University, Portland, Oregon, United States
Lucentis (Ranibizumab) for Eales' Disease
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2019-06-11
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 1
- Registration Number
- NCT00384449
- Locations
- ๐บ๐ธ
Casey Eye Institute, Portland, Oregon, United States
Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients
- Conditions
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2006-08-17
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 200
- Registration Number
- NCT00364052
Methylphenidate and Parkinson's Disease
- First Posted Date
- 2006-08-02
- Last Posted Date
- 2018-11-29
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 13
- Registration Number
- NCT00359723
- Locations
- ๐บ๐ธ
Department of Neurology, OP-2, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon, United States
Trial of Memantine for Cognitive Impairment in Multiple Sclerosis
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-03-09
- Last Posted Date
- 2019-10-15
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 82
- Registration Number
- NCT00300716
- Locations
- ๐บ๐ธ
OHSU, Portland, Oregon, United States
๐บ๐ธUSC, Los Angeles, California, United States
๐บ๐ธMS Hub, Seattle, Washington, United States
A Clinical Trial of Infliximab for Uveitis
Not Applicable
Completed
- Conditions
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2011-07-04
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 32
- Registration Number
- NCT00273390
Measuring Preferences for Childbirth After Cesarean
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-12-21
- Last Posted Date
- 2019-12-11
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 131
- Registration Number
- NCT00267735
- Locations
- ๐บ๐ธ
Oregon Health & Science University Clinics, Portland, Oregon, United States
Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
- First Posted Date
- 2005-12-01
- Last Posted Date
- 2019-05-24
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 1
- Registration Number
- NCT00260299
- Locations
- ๐บ๐ธ
Oregon Health & Science University, Portland, Oregon, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath